Why the US Pharmacogenomics Market Distribution is Key to Future...

added blog Health

2026-07-10 06:29:13 -

Why the US Pharmacogenomics Market Distribution is Key to Future Healthcare Advances

As the US Pharmacogenomics Market Distribution evolves, it promises to redefine the landscape of healthcare delivery and patient management. With a market size poised to reach $2.58 billion by 2035, the sector is experiencing a paradigm shift towards personalized medicine. According to , the projected compound annual growth rate (CAGR) of 7.47% reflects a growing recognition of the value of...

0 Comments 0 Shares 224 Views 0 Reviews